Encompass Health CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Greg D Carmichael, a Director of Encompass Health Corp, received 28 shares of common stock on October 15, 2026.
NYSE
Terrance Williams, a Director of Encompass Health Corp, received 28 shares of common stock on October 15, 2026.
NYSE
Nancy M Schlichting, a Director of Encompass Health Corp, received 38 shares of common stock on October 15, 2026.
NYSE
Joan E Herman, a Director of Encompass Health Corp, received 81 shares of common stock on October 15, 2026.
NYSE
Edward M Christie Iii, a Director of Encompass Health Corp, reported multiple transactions in common stock on October 15, 2026.
NYSE
Christopher R Reidy, a Director of Encompass Health Corp, reported multiple transactions in common stock on October 15, 2026.
NYSE
Cain A Hayes, a Director of Encompass Health Corp, received 4 shares of common stock on October 15, 2026.
NYSE
Kevin J. O'Connor, a Director of Encompass Health Corp, received 18 shares of common stock on October 15, 2026.
NYSE
Leslye G Katz, a Director of Encompass Health Corp, received 81 shares of common stock on October 15, 2026.
NYSE
Andrew L Price, Chief Accounting Officer of Encompass Health Corp, sold 5,211 shares of common stock on August 31, 2026 for $120.93 per share.
NYSE
John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, sold 4,858 shares of common stock on August 31, 2026 for $121.09 per share.
NYSE
Douglas E Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, sold 18,869 shares of common stock on August 10, 2026 for $125.38 per share.
NYSE
Mark J Tarr, President & CEO and a Director of Encompass Health Corp, sold 173,148 shares of common stock on August 10, 2026.
NYSE
John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, sold 8,906 shares of common stock on August 10, 2026 for $125.95 per share.
NYSE
Christopher R Reidy, a Director of Encompass Health Corp, reported multiple transactions in common stock on July 15, 2026.
NYSE
Edward M Christie Iii, a Director of Encompass Health Corp, reported multiple transactions in common stock on July 15, 2026.
NYSE
Terrance Williams, a Director of Encompass Health Corp, received 29 shares of common stock on July 15, 2026.
NYSE
Nancy M Schlichting, a Director of Encompass Health Corp, received 40 shares of common stock on July 15, 2026.
NYSE
Kevin J. O'Connor, a Director of Encompass Health Corp, received 19 shares of common stock on July 15, 2026.
NYSE
Leslye G Katz, a Director of Encompass Health Corp, received 85 shares of common stock on July 15, 2026.
NYSE
Joan E Herman, a Director of Encompass Health Corp, received 85 shares of common stock on July 15, 2026.
NYSE
Cain A Hayes, a Director of Encompass Health Corp, received 4 shares of common stock on July 15, 2026.
NYSE
Greg D Carmichael, a Director of Encompass Health Corp, received 29 shares of common stock on July 15, 2026.
NYSE
Encompass Health Corp. EVP & CFO Douglas E. Coltharp reported transactions involving company stock, including the acquisition of shares via options and subsequent sales.
NYSE
Encompass Health Corp. reports a stock transaction by EVP, Chief Operating Officer Patrick William Tuer.
NYSE
Encompass Health Corp. director Kevin J. O'Connor acquired 1,634 shares of common stock through an annual restricted stock unit grant.
NYSE
Encompass Health Corp. director Edward M. Christie III acquired 1,634 restricted stock units as part of an annual grant.
NYSE
Encompass Health Corp. reports that Director Christopher R. Reidy acquired 1,634 restricted stock units under the company's 2025 Omnibus Performance Incentive Plan.
NYSE
Encompass Health Corp. director Cain A. Hayes was granted restricted stock units as part of an annual incentive plan.
NYSE
Encompass Health Corp. reports a Form 4 filing detailing a stock acquisition by Director Greg D. Carmichael.